Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
European Growth Companies With High Insider Ownership In February 2026
European Growth Companies With High Insider Ownership In February 2026
Simply Wall St
Thu, February 19, 2026 at 2:35 PM GMT+9 4 min read
In this article:
OTGLF
-14.25%
HSHP
+3.47%
VIMGF
+62.45%
MILDEF.ST
+3.71%
KEBNI-B.ST
-5.57%
As of February 2026, the European markets have experienced volatility, with the pan-European STOXX Europe 600 Index reaching new highs but ending the week with only a slight gain amid concerns about AI disruption and strong U.S. job data. In this fluctuating environment, growth companies with high insider ownership can offer potential resilience and alignment of interests between management and shareholders, making them intriguing options for investors looking to navigate these uncertain times.
Top 10 Growth Companies With High Insider Ownership In Europe
Click here to see the full list of 213 stocks from our Fast Growing European Companies With High Insider Ownership screener.
Let’s uncover some gems from our specialized screener.
Himalaya Shipping
Simply Wall St Growth Rating: ★★★★★☆
Overview: Himalaya Shipping Ltd. offers dry bulk shipping services globally and has a market cap of NOK5.72 billion.
Operations: The company generates revenue primarily through its transportation and shipping segment, which amounted to $131.90 million.
Insider Ownership: 30.4%
Himalaya Shipping demonstrates potential as a growth company with high insider ownership in Europe. Despite slower revenue growth at 7.1% annually, its earnings are forecast to grow significantly, outpacing the Norwegian market. Recent financial results show substantial improvement, with Q4 2025 net income rising to US$13.5 million from US$1.1 million year-on-year. Though interest payments aren’t well-covered by earnings, strong future earnings projections and strategic time charter agreements bolster its growth prospects amidst fluctuating dividend distributions.
OB:HSHP Earnings and Revenue Growth as at Feb 2026
Vimian Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Vimian Group AB operates in the global animal health industry and has a market capitalization of SEK14.04 billion.
Operations: The company’s revenue is derived from its Medtech segment (€155.50 million), Diagnostics segment (€22.90 million), Specialty Pharma segment (€182.40 million), and Veterinary Services segment (€64.50 million).
Insider Ownership: 12.7%
Vimian Group’s earnings are projected to grow significantly at 28% annually, surpassing the Swedish market. Although revenue growth is moderate at 8.7%, recent financials show a full-year sales increase to €425 million from €374.8 million, with net income rising to €31.3 million from €18.5 million year-on-year. Trading below fair value by 21.9% and analysts forecasting a price rise of 27%, Vimian’s growth potential remains robust despite low forecasted return on equity at 9.2%.
OM:VIMIAN Earnings and Revenue Growth as at Feb 2026
Idorsia
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Idorsia Ltd is a biopharmaceutical company focused on discovering, developing, and commercializing drugs for unmet medical needs across Switzerland, the United States, Japan, Europe, China, and Canada with a market cap of CHF998.48 million.
Operations: The company’s revenue is primarily generated from its activities in discovering, developing, and commercializing drugs, amounting to CHF232.51 million.
Insider Ownership: 24.5%
Idorsia is poised for significant growth, with earnings forecasted to expand 64.6% annually as it transitions to profitability within three years. Despite a volatile share price and past shareholder dilution, its revenue growth of 19.1% outpaces the Swiss market average. Recent developments include a Phase 3 program for lucerastat targeting Fabry disease and an exclusive agreement with EMS S.A. to distribute QUVIVIQ in Latin America, highlighting Idorsia’s strategic expansion efforts and innovative pipeline potential.
SWX:IDIA Ownership Breakdown as at Feb 2026
Next Steps
_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years._
Companies discussed in this article include OB:HSHP OM:VIMIAN and SWX:IDIA.
Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_
Terms and Privacy Policy
Privacy Dashboard
More Info